JEMCX Performance — JPMorgan Emerging Markets Equity Fund, Class C
Data updated: 2026-09-28
JEMCX returned +23.20% year to date and +45.29% over one year to Jul 2026. Annualised returns are +19.45% over 3 years and +5.25% over 5 years. The fund beat its Emerging Markets Equity category average: $100 invested three years ago grew to $170, against $164 for the category, and to $145 over one year, against $134. Volatility over the past three years was 17.29% a year. In the 12 months to Jul 2026 the fund lost a net $580.0M, and assets reached $10.84B.
JEMCX Growth of $100
What $100 invested in JPMorgan Emerging Markets Equity Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Equity category average over the same months.
| Period | JEMCX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $145 | $134 |
| 3 years (Aug 2023 – Jul 2026) | $170 | $164 |
| 5 years (Aug 2021 – Jul 2026) | $129 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $179 | $188 |
JEMCX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +23.20% |
| 1 year | +45.29% |
| 3 years (annualised) | +19.45% |
| 5 years (annualised) | +5.25% |
JEMCX Annual Returns
Calendar-year total returns of JPMorgan Emerging Markets Equity Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +23.20% |
| 2025 | +39.04% |
| 2024 | +2.62% |
| 2023 | +6.43% |
| 2022 | −26.31% |
| 2021 | −10.99% |
| 2020 | +33.71% |
| 2019 (Aug–Dec) | +9.04% |
JEMCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +10.1% | +3.7% | −9.0% | +14.8% | +8.2% | +2.4% | −6.8% | — | — | — | — | — |
| 2025 | +3.1% | −0.6% | +1.1% | +0.5% | +5.6% | +6.4% | +0.8% | +3.4% | +8.6% | +3.9% | −1.9% | +2.9% |
| 2024 | −4.4% | +4.6% | +2.4% | −1.6% | +1.6% | +2.9% | −1.0% | +1.3% | +4.0% | −3.3% | −2.7% | −0.7% |
| 2023 | +10.0% | −6.4% | +1.9% | −1.5% | −1.9% | +4.6% | +3.5% | −6.9% | −3.8% | −2.7% | +7.4% | +3.6% |
| 2022 | −5.0% | −7.6% | −4.5% | −6.9% | +0.8% | −4.7% | +1.0% | −1.4% | −11.1% | −3.1% | +17.5% | −2.6% |
| 2021 | +2.7% | −1.2% | −3.9% | +2.2% | +1.7% | +1.4% | −7.6% | +3.7% | −4.8% | +0.8% | −5.2% | −0.7% |
| 2020 | −3.3% | −3.0% | −17.1% | +8.4% | +4.5% | +9.6% | +9.1% | +6.2% | −1.7% | +3.8% | +8.1% | +8.3% |
| 2019 | — | — | — | — | — | — | — | −3.1% | +1.5% | +4.5% | +0.3% | +5.8% |
JEMCX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 17.29%
- 3-year Sharpe ratio: 0.86 (vs 4.5% risk-free rate)
- Best month: +14.78% (Apr 2026)
- Worst month: −8.95% (Mar 2026)
JEMCX Fund Flows
Monthly money in and out of JPMorgan Emerging Markets Equity Fund, from SEC Form N-PORT.
- 12-month net flow: −$580.0M
- 12-month gross sales (incl. reinvestments): $2.7B
- Sales ÷ redemptions: 0.82×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $177.3M | $239.6M | −$62.3M |
| Jun 2026 | $162.7M | $347.8M | −$185.1M |
| May 2026 | $154.1M | $392.3M | −$238.2M |
| Apr 2026 | $186.6M | $319.2M | −$132.6M |
| Mar 2026 | $158.9M | $252.7M | −$93.8M |
| Feb 2026 | $167.3M | $257.1M | −$89.8M |
| Jan 2026 | $175.9M | $327.7M | −$151.8M |
| Dec 2025 | $262.6M | $274.6M | −$12.0M |
| Nov 2025 | $381.4M | $202.6M | $178.8M |
| Oct 2025 | $120.2M | $227.3M | −$107.2M |
| Sep 2025 | $119.6M | $191.7M | −$72.2M |
| Aug 2025 | $600.8M | $214.8M | $386.1M |
JEMCX Assets Under Management
Net assets of JPMorgan Emerging Markets Equity Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $10.84B |
| 2026-04-30 | $10.94B |
| 2026-01-31 | $10.38B |
| 2025-10-31 | $9.42B |
| 2025-07-31 | $7.83B |
| 2025-04-30 | $6.26B |
| 2025-01-31 | $6.60B |
| 2024-10-31 | $6.98B |
| 2024-07-31 | $7.00B |
| 2024-04-30 | $7.12B |
| 2024-01-31 | $7.22B |
| 2023-10-31 | $7.09B |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.